A Study to Compare the Pharmacokinetics of Budesonide Delivered by PT027 Compared With Pulmicort Flexhaler (ELBRUS)
Status:
Completed
Trial end date:
2019-09-10
Target enrollment:
Participant gender:
Summary
This study is to compare the systemic exposure of budesonide delivered by the combination
inhaler (budesonide/albuterol sulfate pressurized inhalation suspension [BDA metered dose
inhaler {BDA MDI}]) with Pulmicort Flexhaler dry-powder inhaler (DPI).